Alpha 2.0
Login Register
» Authors » Annelotte C M van Bommel

Annelotte C M van Bommel

Explore the profile of Annelotte C M van Bommel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 360
Followers 0
Related Specialties
Oncology
General Surgery
General Medicine
Top 10 Co-Authors
Marc A M Mureau
Sabine Siesling
Thijs van Dalen
Carolien H Smorenburg
Caleb Stowell
Danny A Young-Afat
Vivianne C G Tjan-Heijnen
Marie-Jeanne T F D Vrancken Peeters
J Juliet Vrolijk
Michel W J M Wouters
Published In
Breast Cancer Res Treat
Plast Reconstr Surg
JAMA Oncol
BMJ Case Rep
J Surg Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Increasing Rates but Persistent Variability of Immediate Breast Reconstruction: Real-Time Data from a Population-Based Study (2012-2022)
Heeling E, Kramer G, Volders J, van Bommel A, van der Ploeg I, Hoornweg M, et al.
Ann Surg Oncol . 2024 Nov; 32(3):1997-2006. PMID: 39560828
Introduction: Preserving the breast contour after mastectomy is proven to be beneficial for the quality of life of a large group of patients with breast cancer (BC). The aim of...
2.
Long-Term Outcomes of 1989 Immediate Implant-Based Breast Reconstructions: An Analysis of Risk Factors for Failure and Revision Surgery
Kooijman M, van Bommel A, van Duijnhoven F, Scholten A, Smorenburg C, Woerdeman L, et al.
Plast Reconstr Surg . 2024 Sep; 155(3):469e-478e. PMID: 39315798
Background: Nipple- or skin-sparing mastectomy and immediate implant-based breast reconstruction (IBR) is potentially associated with long-term unfavorable outcomes, such as revision surgery and reconstruction failure. This large patient cohort study...
3.
Ensuring access to post-cancer breast reconstructions: COVID-19 lessons from the Dutch Breast Implant Registry
Vrolijk J, Young-Afat D, Mureau M, Rakhorst H, van Bommel A, Hoornweg M
Eur J Surg Oncol . 2023 Aug; 49(9):106984. PMID: 37543001
Background: COVID-19 has impacted breast implant surgery for oncological and non-oncological patients worldwide. This population-based study aimed to evaluate the impact of the COVID-19 pandemic on access to reconstructive and...
4.
Risk Factors for Unplanned Reoperation during the Expansion Phase in Two-Stage Breast Reconstruction in the Dutch Breast Implant Registry
Vrolijk J, Bargon C, Becherer B, Wilschut J, van Bommel A, Hommes J, et al.
Plast Reconstr Surg . 2023 Jul; 154(1):33e-43e. PMID: 37506354
Background: The majority of postmastectomy breast reconstructions (PMBRs) are currently performed in two stages using a tissue expander (TE). However, complications during the expansion phase occur regularly, leading to unplanned...
5.
Using a Digital Implant Catalog Improves Data Quality and Reduces Administrative Burden in the Dutch Breast Implant Registry
Barati N, Vrolijk J, Becherer B, van Bommel A, Hommes J, Mureau M, et al.
Aesthet Surg J . 2021 Sep; 42(5):NP275-NP281. PMID: 34555146
Background: Correct registration of implant characteristics is essential to monitor implant safety within implant registries. Currently, in the nationwide Dutch Breast Implant Registry (DBIR), these characteristics are being registered manually...
6.
Discrepancies Between Surgical Oncologists and Plastic Surgeons in Patient Information Provision and Personal Opinions Towards Immediate Breast Reconstruction
van Bommel A, Schreuder K, Veenstra R, de Ligt K, Vrancken Peeters M, Maduro J, et al.
Ann Plast Surg . 2018 Aug; 81(4):383-388. PMID: 30067531
Background: Immediate breast reconstruction (IBR) may improve quality of life of patients receiving mastectomy. However, a significant hospital variation exists in the use of IBR due to various reasons. To...
7.
Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor-Positive Early Breast Cancer: Results of a Prospective Cohort Study
Kuijer A, Straver M, den Dekker B, van Bommel A, Elias S, Smorenburg C, et al.
J Clin Oncol . 2017 Aug; 35(24):2814-2819. PMID: 28813638
Purpose Gene-expression profiles increasingly are used in addition to conventional prognostic factors to guide adjuvant chemotherapy (CT) decisions. The Dutch guideline suggests use of validated gene-expression profiles in patients with...
8.
Breast magnetic resonance imaging use in patients undergoing neoadjuvant chemotherapy is associated with less mastectomies in large ductal cancers but not in lobular cancers
Vriens I, Keymeulen K, Lobbes M, van Bommel A, Nieuwenhuijzen G, Smidt M, et al.
Eur J Cancer . 2017 Jun; 81:74-80. PMID: 28618304
Background: To assess the impact of breast magnetic resonance imaging (MRI) use on surgical outcome per histological breast cancer subtype in patients treated with neoadjuvant chemotherapy. Patients And Methods: All...
9.
An International Collaborative Standardizing a Comprehensive Patient-Centered Outcomes Measurement Set for Colorectal Cancer
Zerillo J, Schouwenburg M, van Bommel A, Stowell C, Lippa J, Bauer D, et al.
JAMA Oncol . 2017 Apr; 3(5):686-694. PMID: 28384684
Importance: Global health systems are shifting toward value-based care in an effort to drive better outcomes in the setting of rising health care costs. This shift requires a common definition...
10.
Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers
Lobbes M, Vriens I, van Bommel A, Nieuwenhuijzen G, Smidt M, Boersma L, et al.
Breast Cancer Res Treat . 2017 Jan; 162(2):353-364. PMID: 28132393
Purpose: In this retrospective population-based cohort study, we analyzed breast MRI use and its impact on type of surgery, surgical margin involvement, and the diagnosis of contralateral breast cancer. Methods:...